Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin

Information on the rate and timing of hepatitis C virus (HCV) relapse after treatment with pegylated interferon plus ribavirin is scarce. Among 604 patients treated for chronic hepatitis C, the 386 who were human immunodeficiency virus (HIV) positive attained an end-of-treatment response less freque...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2009-11, Vol.49 (9), p.1397-1401
Main Authors: Medrano, José, Barreiro, Pablo, Resino, Salvador, Tuma, Paula, Rodríguez, Violeta, Vispo, Eugenia, Labarga, Pablo, Madejón, Antonio, García-Samaniego, Javier, Jiménez-Nácher, Inmaculada, Martín-Carbonero, Luz, Soriano, Vincent
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Information on the rate and timing of hepatitis C virus (HCV) relapse after treatment with pegylated interferon plus ribavirin is scarce. Among 604 patients treated for chronic hepatitis C, the 386 who were human immunodeficiency virus (HIV) positive attained an end-of-treatment response less frequently and experienced relapse more often than did the 218 who were HIV negative. However, episodes of HCV relapse occurred before week 12 in most cases, regardless of HIV status.
ISSN:1058-4838
1537-6591
DOI:10.1086/630205